
Dry eye disease affects millions of Americans, causing symptoms like burning, stinging, blurry vision, redness, and a persistent gritty sensation. While artificial tears may offer temporary relief, many patients need prescription treatment that addresses the underlying cause of their condition.
Two of the newest prescription options - XDEMVY and MIEBO - have generated significant attention. But which one is more effective?
At Barry Huse OD & Associates, we help patients find targeted solutions based on the specific cause of their dry eye. Here’s what you should know about these advanced treatments.
Dry eye disease is complex and often caused by more than one factor. The two most common contributors are evaporative dry eye, typically linked to meibomian gland dysfunction (MGD), and inflammatory or Demodex-related blepharitis, which involves microscopic mites that affect the eyelids and lash follicles.
Because these causes are different, treatment effectiveness depends on identifying what is actually driving your symptoms.
XDEMVY (lotilaner ophthalmic solution 0.25%) is the first FDA-approved eye drop specifically designed to treat Demodex blepharitis. Demodex mites live in the hair follicles of the eyelashes and can contribute to eyelid inflammation, irritation, and chronic dry eye symptoms.
XDEMVY works by targeting and eliminating these mites. As the infestation clears, inflammation along the eyelids decreases, which can significantly reduce redness, irritation, and debris at the lash line.
This medication is particularly effective for patients who experience itchy eyelids, crusting around the lashes, or persistent lid inflammation that has not improved with standard dry eye treatments.
MIEBO (perfluorohexyloctane ophthalmic solution) is designed to treat evaporative dry eye. Instead of increasing tear production, it stabilizes the tear film by forming a protective layer over the eye’s surface.
This helps prevent tears from evaporating too quickly, which is especially helpful for patients with meibomian gland dysfunction. When the oil glands in the eyelids are not functioning properly, the tear film becomes unstable, leading to burning, stinging, and symptoms that often worsen in windy environments or with prolonged screen use.
MIEBO directly addresses this evaporation issue, helping retain moisture and improve overall comfort.
There is no single “more effective” option across the board. The better choice depends entirely on the underlying cause of your dry eye.
If Demodex mites and eyelid inflammation are contributing to your symptoms, XDEMVY is typically the more effective solution because it treats the root problem. On the other hand, if your dry eye is primarily caused by tear evaporation due to meibomian gland dysfunction, MIEBO is often the more appropriate and effective treatment.
In some cases, patients may have overlapping causes. For example, someone may have both MGD and Demodex blepharitis. When that happens, a combined or staged treatment approach may provide the best results.
If artificial tears provide only short-term relief, or if your symptoms interfere with work, driving, or screen time, it may be time to consider prescription treatment. Chronic redness, eyelid irritation, or recurring crusting are also signs that a more targeted approach may be necessary.
Newer medications like XDEMVY and MIEBO represent an important advancement in dry eye care because they are designed to address specific mechanisms of disease rather than simply adding lubrication.
So, which eye drops are more effective for dry eye: XDEMVY or MIEBO?
The answer depends on the cause of your condition. XDEMVY is highly effective for treating Demodex-related blepharitis, while MIEBO is designed to manage evaporative dry eye associated with meibomian gland dysfunction. The most effective treatment is the one that targets your specific diagnosis.
At Barry Huse OD & Associates, we provide comprehensive dry eye assessments and personalized treatment plans tailored to your needs. Visit our office in Tacoma, Washington, or call (253) 473-1050 to book an appointment today.